Genetics reveal why people respond differently to GLP-1 weight-loss drugs

A study published in Nature identifies genetic variants in GLP1R and GIPR genes as key factors influencing individual responses to GLP-1-based weight-loss drugs. These variants may explain varying drug effectiveness and potential adverse effects among patients.